Status:
COMPLETED
Effects of Continuous Positive Airway Pressure (CPAP) Treatment on Glucose Control in Patients With Type 2 Diabetes
Lead Sponsor:
University of Chicago
Conditions:
Obstructive Sleep Apnea
Type 2 Diabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The overall goal of the proposed protocol is to rigorously test the hypothesis that CPAP treatment has beneficial effects on glycemic control in patients with both type 2 diabetes (T2DM) and obstructi...
Eligibility Criteria
Inclusion
- Male and female subjects with type 2 diabetes on a stable medication regimen (no change in diabetic medications in the previous 3 months) will be eligible.
Exclusion
- Subjects on insulin will be excluded.
- Subjects with unstable cardiopulmonary disease, painful neuropathy, significant psychiatric illness, cognitive impairment and pregnancy will be excluded.
- Shift workers
- Subjects having traveled across \>2 time zones less than one month prior to the study
- Diagnosis of a sleep disorder other than OSA by screening polysomnography
- Previous treatment with positive airway pressure or supplemental oxygen
- Requirement of supplemental oxygen or bi-level positive airway pressure for OSA treatment during titration
- Claustrophobia or other conditions of CPAP intolerance,
- Presence of active infection.
Key Trial Info
Start Date :
November 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2015
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT01136785
Start Date
November 1 2009
End Date
August 1 2015
Last Update
April 10 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Chicago
Chicago, Illinois, United States, 60637